Further research is needed to elucidate the specific role of PD-L1 in soft tissue tumors, even liposarcomas immune evasion, and to explore alternative strategies to enhance the effectiveness of immunotherapy in this type of cancer. Here, CD274 is linked to soft tissue neoplasm.